在治疗耐药精神分裂症的患者中减少克洛扎宾剂量:一个病例系列
Mohammed A Alarabi1,2, Akash Prasanna Kumar1, Valerie Powell1
1Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), 1051 Queen Street West, Toronto, Ontario M6J 1H3, Canada.
Schizophrenia bulletin
|August 22, 2025
概括
在治疗耐药性精神分裂症 (TRS) 患者中,降低克洛扎的使用率具有很高的复发风险. 根据克洛扎水平逐步降低剂量可能会减轻这种风险,但需要进行更大规模的研究.
科学领域:
- 精神病学
- 药理学
- 临床医学
背景情况:
- 在缓解治疗耐药性精神分裂症 (TRS) 患者中,关于克洛扎宾降低处方结果的证据有限.
- 本研究研究了在TRS患者中实现缓解的克洛扎宾剂量降低.
研究的目的:
- 在缓解治疗耐药精神分裂症的患者中研究降低克洛扎宾剂量的结果.
- 在该群体中评估与克洛扎不再处方相关的复发风险.
主要方法:
- 对9名用克洛扎治疗的TRS患者的回顾性病理表.
- 包括标准:TRS诊断,克洛扎宾缓解,维持剂量减少> 25%.
- 收集了关于缓解状态,复发,克洛扎水平和剂量减少率的数据.
主要成果:
- 在降低剂量后,44. 4% 的患者保持缓解.
- 33. 3% 的患者复发并需要增加剂量; 22. 2% 的患者复发并需要住院治疗.
- 观察到缓慢的缓解率 (例如每12周25毫克),缓慢的缓解率可能与持续缓解有关.
结论:
- 在缓解TRS患者中,减少克洛扎宾的剂量会带来很大的复发风险.
- 根据克洛扎水平逐渐减少剂量可能会降低复发风险.
- 需要对更大群体进行进一步的研究,以确定TRS患者的复发预测因子.
相关概念视频
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
Antipsychotic Drugs: Typical and Atypical Agents
314
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
314
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
296
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
296
Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344


